Sandra H. Thomas

3.2k total citations
60 papers, 1.9k citations indexed

About

Sandra H. Thomas is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Sandra H. Thomas has authored 60 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 19 papers in Hematology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Sandra H. Thomas's work include CAR-T cell therapy research (16 papers), Lymphoma Diagnosis and Treatment (14 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Sandra H. Thomas is often cited by papers focused on CAR-T cell therapy research (16 papers), Lymphoma Diagnosis and Treatment (14 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Sandra H. Thomas collaborates with scholars based in United States, United Kingdom and Australia. Sandra H. Thomas's co-authors include Stephen J. Forman, Joycelynne Palmer, Robert Chen, Auayporn Nademanee, Ni‐Chun Tsai, Leslie Popplewell, Wen-Chung Chang, Xiuli Wang, Ryan Urak and T. O. NUNAN and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Sandra H. Thomas

58 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra H. Thomas United States	25	978	471	409	386	351	60	1.9k
Sairah Ahmed United States	23	1.4k 1.4×	484 1.0×	517 1.3×	597 1.5×	277 0.8×	219	2.1k
Aleksandr Lazaryan United States	21	797 0.8×	275 0.6×	443 1.1×	678 1.8×	186 0.5×	103	1.7k
Christoph Faul Germany	22	1.3k 1.3×	445 0.9×	608 1.5×	1.1k 2.9×	278 0.8×	82	2.5k
Kenneth G. Lucas United States	25	1.2k 1.2×	259 0.5×	673 1.6×	265 0.7×	326 0.9×	56	2.2k
Nathalie Parquet France	21	480 0.5×	261 0.6×	281 0.7×	449 1.2×	205 0.6×	55	1.4k
Pere Barba Spain	24	826 0.8×	201 0.4×	226 0.6×	709 1.8×	173 0.5×	90	1.6k
Ludvig A. Munthe Norway	22	482 0.5×	184 0.4×	937 2.3×	567 1.5×	393 1.1×	76	2.4k
Donald E. Tsai United States	32	1.8k 1.8×	1.2k 2.5×	431 1.1×	537 1.4×	596 1.7×	117	3.3k
Jacopo Peccatori Italy	27	1.3k 1.3×	159 0.3×	1.0k 2.5×	1.1k 2.8×	398 1.1×	114	2.8k
Susana Rives Spain	20	712 0.7×	604 1.3×	157 0.4×	274 0.7×	231 0.7×	70	1.4k

Countries citing papers authored by Sandra H. Thomas

Since Specialization

Citations

This map shows the geographic impact of Sandra H. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra H. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra H. Thomas more than expected).

Fields of papers citing papers by Sandra H. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra H. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra H. Thomas. The network helps show where Sandra H. Thomas may publish in the future.

Co-authorship network of co-authors of Sandra H. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra H. Thomas. A scholar is included among the top collaborators of Sandra H. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra H. Thomas. Sandra H. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xiuli, Miriam Walter, Ryan Urak, et al.. (2017). Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor–Redirected T Cells Against Multiple Myeloma. Clinical Cancer Research. 24(1). 106–119. 149 indexed citations

Urak, Ryan, Miriam Walter, Laura Lim, et al.. (2017). Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy. Journal for ImmunoTherapy of Cancer. 5(1). 26–26. 85 indexed citations

Wang, Xiuli, ChingLam W. Wong, Ryan Urak, et al.. (2015). CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells. Clinical Cancer Research. 21(13). 2993–3002. 52 indexed citations

Chen, Robert, Edward M. Newman, Young Kim, et al.. (2015). CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab Vedotin. Molecular Cancer Therapeutics. 14(6). 1376–1384. 158 indexed citations

Chen, Robert, Paul Frankel, Leslie Popplewell, et al.. (2015). A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma. Haematologica. 100(3). 357–362. 61 indexed citations

Khaled, Samer K., Joycelynne Palmer, Josef Herzog, et al.. (2015). Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(2). 268–276. 34 indexed citations

Mei, Matthew, Sandra H. Thomas, & Robert Chen. (2013). Management of Relapsed or Refractory Hodgkin Lymphoma with Second-Generation Antibody–Drug Conjugates: Focus on Brentuximab Vedotin. BioDrugs. 28(3). 245–251. 13 indexed citations

Khaled, Samer K., Joycelynne Palmer, Tracey Stiller, et al.. (2013). Influence of Drug Absorption, Distribution, Metabolism, and Excretion (ADME) Variants on Sirolimus Blood Levels in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 19(2). S330–S330. 5 indexed citations

Shayani, Sepideh, Joycelynne Palmer, Tracey Stiller, et al.. (2012). Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease Prophylaxis. Biology of Blood and Marrow Transplantation. 19(2). 298–304. 79 indexed citations

10.

Nakamura, Ryotaro, Joycelynne Palmer, Margaret O’Donnell, et al.. (2012). Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis. Leukemia Research. 36(9). 1152–1156. 25 indexed citations

11.

Khaled, Samer K., Sandra H. Thomas, & Stephen J. Forman. (2012). Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in adults. Current Opinion in Oncology. 24(2). 182–190. 20 indexed citations

12.

Krishnan, Amrita, Joycelynne Palmer, Ni‐Chun Tsai, et al.. (2011). Matched-Cohort Analysis of Autologous Hematopoietic Cell Transplantation with Radioimmunotherapy versus Total Body Irradiation–Based Conditioning for Poor-Risk Diffuse Large Cell Lymphoma. Biology of Blood and Marrow Transplantation. 18(3). 441–450. 29 indexed citations

13.

Delioukina, Maria, et al.. (2011). Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine–melphalan conditioning for treatment of mature T-cell lymphomas. Bone Marrow Transplantation. 47(1). 65–72. 31 indexed citations

14.

Zain, Jasmine, Joycelynne Palmer, Maria Delioukina, et al.. (2011). Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control. Leukemia & lymphoma. 52(8). 1463–1473. 27 indexed citations

15.

Sahebi, Firoozeh, Paul Frankel, Len Farol, et al.. (2011). Sequential Bortezomib, Dexamethasone, and Thalidomide Maintenance Therapy after Single Autologous Peripheral Stem Cell Transplantation in Patients with Multiple Myeloma. Biology of Blood and Marrow Transplantation. 18(3). 486–492. 12 indexed citations

16.

Rosenthal, Joseph, et al.. (2010). Transplant‐associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus. Pediatric Blood & Cancer. 57(1). 142–146. 32 indexed citations

17.

Thomas, Sandra H., et al.. (2007). Initial Experiences with Subcutaneous Recombinant Human Hyaluronidase. Journal of Palliative Medicine. 10(4). 861–864. 42 indexed citations

18.

Carman, Jane, M.G. Garner, Michael Catton, et al.. (1998). Viral haemorrhagic disease of rabbits and human health. Epidemiology and Infection. 121(2). 409–418. 8 indexed citations

19.

Thomas, Sandra H., et al.. (1990). Clinical versus Biochemical Assessment in Thyroxine Replacement Therapy: A Retrospective Study. Journal of the Royal College of Physicians of London. 24(4). 289–291. 2 indexed citations

20.

O’Doherty, Michael, Clive Page, C Bradbeer, et al.. (1988). DIFFERENCES IN RELATIVE EFFICIENCY OF NEBULISERS FOR PENTAMIDINE ADMINISTRATION. The Lancet. 332(8623). 1283–1286. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact